CMS Releases State Funding Notice for CGT Access Model

The Centers for Medicare and Medicaid Services (CMS) released a state funding notice for the Cell and Gene Therapy (CGT) Access Model on Aug. 15. The CGT Access Model is a voluntary model for states and CGT manufacturers that tests whether a CMS-led approach to developing and administering outcomes-based agreements for cell and gene therapies improves Medicaid beneficiaries’ access to innovative treatment, improves their health outcomes and reduces health care costs and burdens to state Medicaid programs. The model will initially focus on gene therapies for sickle cell disease. 

A maximum of $9.55 million may be awarded to each recipient, depending on the number of states that apply for funding, pending availability of funds. The application deadline is Feb. 28, 2025. The anticipated award date is July 1, 2025.